Pathnostics Announces the Launch of GUIDANCE Hematuria to Investigate Possible Infectious Causes for Asymptomatic Hematuria

  What You Need to Know:   • American Urological Association (AUA) guidelines suggest an assessment of the asymptomatic microhematuria (AMH) patient should begin with a careful history, physical examination, and laboratory examination to rule out causes of AMH such as an infection.   • GUIDANCE Hematuria is designed to assist with determining whether there […]

read more

The History of Culture Testing

It took nearly 2,500 years to get past the cutting edge practice of tasting urine to diagnose diseases. It has taken less than 150 years to advance from tasting urine, to clinical culture, and on to molecular diagnostics.   Hippocrates (460 – 377 BCE) is said to have been the first to diagnose diabetes.1 One […]

read more
Urogenital Tuberculosis (UGTB)

Urogenital Mycobacterium Tuberculosis: What Should Urologists Know?

I. Executive Summary • M. tuberculosis is a bacterium that causes tuberculosis (TB). • Globally, there were 10.4 million new cases of TB in 2016, with 1.7 million deaths. • In the same year in the U.S., there were 9,272 new cases of TB, with no reported deaths from TB that year. • Although the […]

read more

Pathnostics Celebrates One Month Teaming with Tennessee Urology Associates to Provide GUIDANCE Testing

Tennessee Urology Associates, Tennessee’s premier urologic health care specialists, began providing GUIDANCE testing to their patients on July 23, 2018.   GUIDANCE was previously available only through the Pathnostics laboratory in Irvine, California. Performance of GUIDANCE at Tennessee Urology Associates will allow a more rapid turnaround time, enabling initiation of treatment sooner.   GUIDANCE is […]

read more

GUIDANCE 4.5 From Pathnostics: The most extensive UTI pathogen testing available

At least 50% of women experience a urinary tract infection (UTI), and about 30% suffer recurrent UTI (rUTI). Of those women who have rUTI, nearly 62% face between 4 and 10 UTIs per year.1–3   Although poor patient compliance with treatment and emergence of de novo pathogen resistance can both cause rUTI, more effective treatment […]

read more
UTI

What is the Best Treatment Path for a UTI?

Recurrent urinary tract infections (UTIs) present a significant health issue for women, with uncomplicated UTI occurring in at least 50% of women, and about 30% experiencing recurrent UTI (rUTI).1–3   Although there are multiple definitions for rUTI, the American Urogynecological Society published a best-practice statement for rUTI this year (2018) with rUTI defined as “at […]

read more

Human Herpes Virus 6 and 7

I. Overview   • Although both typically cause dermatological infections and both can be a factor in transplant rejection, both have also been found in the bladder and vagina.   • Both HHV-6 and -7 can exist in three different states in the human body: – As an active infection – As a latent infection […]

read more
Several studies have examined methods for providing appropriate infection management while reducing costs.

How to Reduce the Overall Cost of a Urinary Tract Infection

UTI Costs Have Increased > 90% In The Last Decade   • Urinary tract infections (UTI) constitute one of the most common bacterial infections, with over 10.5 million office visits in the U.S. in 2007 alone.1   • Hospitalizations for UTI increased dramatically: cases increased by 76% and incidence increased by 52% between 1998 and 2011.   […]

read more
Pathnostics Blog - A Diagnostics Solutions Company

Group A Streptococcus: Diagnosis and Management of Group A Strep Urogenital Infections

• Group A Streptococcus infection is one of the top ten causes of infection-related mortality worldwide.   • Group A Streptococcus is commonly used as an alternative label for Streptococcus pyogenes (S. pyogenes), the predominant group A Streptococcus species.   • As a genitourinary tract infection, S. pyogenes is most commonly found as a postpartum […]

read more